Objectives: Multiply antibiotic-resistant (MAR) mutants of Escherichia coli and Salmonella enterica are characterized by reduced susceptibility to several unrelated antibiotics, biocides and other xenobiotics. Porin loss and/ or active efflux have been identified as a key mechanisms of MAR. A single rapid test was developed for MAR.
Introduction
The intrinsic resistance to multiple unrelated antibiotics and disinfectants of Gram-negative bacteria is mediated by innate mechanisms and is principally defined by expression of efflux pump systems and porins. 1 Active efflux has been identified as a common mechanism of multiple antibiotic resistance (MAR) and cyclohexane tolerance in Enterobacteriaceae. 1, 2 The major efflux system of Salmonella and Escherichia coli is the threecomponent AcrAB-TolC system; homologues of this system are also the major determinants of intrinsic resistance to multiple toxic compounds in most Gram-negative species. 2 In Salmonella Typhimurium increased expression of acrB has been associated with reduced susceptibility to ciprofloxacin, chloramphenicol and tetracycline (MAR). 3, 4 Similarly, in E. coli the AcrAB system has been identified as the major pump responsible for reduced susceptibility to multiple antibiotics. 5 AcrB is a trimer anchored in the inner membrane that binds substrate and extends into the periplasm where it joins with the outer membrane protein TolC. AcrA acts as an accessory protein and is the final component of the functional system. 6 -8 This pump is powered by a proton gradient that is used to drive conformational change forcing the extrusion of substrate from a binding pocket in AcrB to the external environment via TolC in exchange for a proton. 9, 10 AcrB is capable of binding an extremely wide range of potential substrates 1 that may carry a positive, negative or no charge. 9 The AcrAB-TolC system is regulated both locally by the repressor AcrR and by global regulator proteins MarA and SoxS, in both Salmonella and E. coli, and in addition by RamA which is present in Salmonella but not E. coli. Overexpression of any of these activators results in de-repression of AcrAB-TolC and this is phenotypically characterized by reduced susceptibility # Crown copyright 2010.
J Antimicrob Chemother 2010; 65: 1655 -1663 doi:10.1093/jac/dkq169 Advance Access publication 30 May 2010 to unrelated antibiotics including tetracycline, chloramphenicol, some penicillins, quinolones, dyes, certain biocides and organic solvents. Typically, the MIC of these agents is raised by 2-to 8-fold. This has been designated as the MAR phenotype. 1 Such MAR mutants are considered to be biologically significant as they have been associated with clinical antibiotic treatment failure in their own right 4 as well as providing a survival platform for acquisition of further specific mutations in antibiotic target sites or acquisition of mobile resistance genes that then confer high-level clinical resistance to antibiotics. To exemplify this, resistance to fluoroquinolones, due to mutation in gyrA, occurs much more readily in E. coli from a MAR background than an isogenic parental strain with normal efflux pump expression.
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Some MAR mutants have been found to be less susceptible to the solvent cyclohexane and consequently this has been evaluated as a single test for this phenotype. Typically, the test is conducted by assessing overnight growth on two agar plates, one flooded with cyclohexane and the other with hexane. The cyclohexane test is limited by its sensitivity and specificity; in a recent study with Salmonella enterica, 81% of cyclohexane-tolerant isolates were MAR; however 44% of cyclohexane-susceptible isolates were also MAR, indicating a poor predictive value of this test. 12 The cellular accumulation of antibiotics has been directly assessed using radiochemical 4, 11 and fluorescent 3, 13 techniques that monitor accumulation of specific antibiotics, but these procedures can be time consuming as separation of bacterial cells and medium is required. Certain fluorescent compounds, such as ethidium bromide, change their wavelength of maximal emission in different environments when intercalating with DNA, and this phenomenon has been exploited to enable discrimination between intra-and extracellular localization of the probe. Such fluorescent intercalators can be substrates of efflux pump systems and represent a class of molecules that can act as reporters of accumulation and efflux activity. Ethidium bromide has been used to assess the contribution of efflux pump and outer membrane permeability to cellular accumulation by different Pseudomonas aeruginosa 14 and E. coli strains. 15 An assay for bacterial efflux pump activity, based on agar plates containing ethidium bromide, has also been described for E. coli and Staphylococcus aureus where temperature difference was used to demonstrate the efflux pump component. 16 However, there are issues associated with the use of ethidium bromide; these include a low quantum yield of 0.3, mutagenic toxicity and selfquenching that can reduce the fluorescence and apparent cellular accumulation, making this an imperfect candidate for assessment of intracellular drug accumulation. 17 Other fluorescent probes have been used to assess cellular accumulation and include 2-(4-dimethylaminostyrul)-1-ethylpyridinium, 14 daunorubicin, doxorubicin and rhodamine derivatives. 18 Several fluorescent probes are substrates of the AcrB efflux pump in E. coli and other bacterial species. 8 Hoechst (H) 33342 (bisbenzimide; Figure 1 ) is a fluorescent probe that has been widely used to measure efflux by mammalian cells and molecular transport by Lactococcus lactis and E. coli. 19 This water-soluble compound is membrane permeable and fluoresces with a high quantum yield when bound to the minor groove of DNA or in a hydrophobic environment such as a lipid membrane, and is relatively non-toxic and non-mutagenic at a concentration of 10 mM.
20 H33342 is a substrate for a wide range of bacterial multidrug resistance transporters 19 and has been used to assess the MAR phenotype conferred on Vibrio cholerae by VcaM, an ABC multidrug efflux pump. 21 In the present study the accumulation of H33342 was evaluated using a range of MAR and gene-disrupted mutants to develop a simple, rapid and sensitive single test to determine intracellular accumulation and identify MAR due to enhanced efflux and/or decreased porin expression in Salmonella Typhimurium. The accumulation of H33342 by MAR mutants of E. coli was also evaluated.
Methods

Strains, media and chemicals
Twenty strains comprising Salmonella Typhimurium and E. coli were used to develop and evaluate an assay based on the intracellular accumulation of the fluorescent probe H33342. The Salmonella strains were all derived from Salmonella enterica serovar Typhimurium SL1344. Gene disruption mutants (with the aph gene that confers kanamycin resistance inserted within the coding sequences of tolC, acrB, acrF, ompF, ompC, ompX and ompW) were prepared as previously described. 22, 23 Seven additional MAR mutants, derived from SL1344 after exposure to toxic substrates of AcrAB-TolC were also evaluated. These included four isogenic MAR mutants (ST-MAR1-4) selected after exposure to tetracycline as described previously when the mar locus was first identified. 24 Three further MAR mutants OXCR1, QACFGR2 and TOPR2 were also obtained Coldham et al.
from SL1344 following repeated treatment with biocides; an oxidizing compound blend (OXCR1), a quaternary ammonium disinfectant containing formaldehyde and glutaraldehyde (QACFGR2) and a tar acids-based disinfectant (TOPR2), respectively, as described and characterized previously. 25 E. coli AG100 and AG102 were used as controls for cyclohexane tolerance assays. 24 Four MAR E. coli strains (EC-MAR1-4), selected after exposure of strain EC19 (a pig isolate) to tetracycline as described above for SL1344, were also evaluated. All strains were routinely cultured on Luria-Bertani without glucose (LB-G) agar and in LB-G broth unless stated otherwise. All chemicals were from Sigma-Aldrich (Poole, Dorset, UK) except for ciprofloxacin, which was kindly donated by Bayer (Newbury, Berkshire, UK).
MICs, cyclohexane resistance and H33342 toxicity
The MICs of antibiotics were determined according to the BSAC agar doubling dilution method. 26 Tolerance to organic solvents (cyclohexane and hexane) was determined as previously described. 27 The toxicity of H33342 (2.5 mM) was determined by incubation of SL1344 at a mid log growth phase optical density of 0.6 (600 nm) for 0, 30, 60 and 120 min of incubation and viability counting of aliquots on LB-G agar plates.
H33342 bisbenzimide accumulation assay
Strains were cultured overnight at 378C and used to inoculate fresh medium that was incubated for a further 5 h at 378C. Bacterial cells were collected by centrifugation at 4000 g and resuspended in PBS (1 mL). The optical density of all suspensions was adjusted to 0.1 at 600 nm 17 and aliquots (0.18 mL) were transferred to wells (n ¼8; 1 strain per column) of a 96-well plate (flat-bottomed, black, supplied by Greiner Bio-one, Stonehouse, UK). The strains were added in the format of column 1, PBS blank; column 2, heat-inactivated SL1344 (10 min 908C); column 3, control strain (SL1344); columns 4 -12, test strains. Eight technical replicates of each strain were analysed in each column. The plate was transferred to a Fluostar Optima (Aylesbury, UK) plate reader, incubated at 378C and H33342 (25 mM) was added (20 mL) to each well using the autoinjector to give a final concentration of 2.5 mM. Fluorescence was read from the top of the wells using excitation and emission filters of 355 and 460 nm, respectively, with 5 flashes/well; readings were taken for 30 cycles with a 75 s delay between cycles, and a gain multiplier of 1460. Raw fluorescence values were analysed using Excel (Microsoft) that included calculation of mean values for each column and subtraction of appropriate control blanks. Each experiment was repeated twice. The statistical significance of differences in the accumulation of H33342 was determined using a paired Student's t-test of each strain compared against appropriate controls such as the parent SL1344. The effect of the inhibitors of efflux, carbonyl cyanide-m-chlorophenyl hydrazone (CCCP) and phenylalanine-arginine-b-naphthylamide (PAbN), was determined by addition immediately before onset of plate reading at timed intervals.
Ethidium bromide accumulation assay
This was measured under identical conditions and in parallel to the H33342 accumulation assay with the exception of the absorption and emission filters, which were of 515 and 600 nm, respectively.
Fluorimetric quinolone accumulation assay
The performance of the H33342 assay was also evaluated by comparison against a previously described protocol for the accumulation of norfloxacin by isogenic mutants lacking a functional TolC or AcrB. 13 Data for the test strains were compared using both methods over an incubation period of 30 min and analysed relative to accumulation by the parental strain SL1344.
Results
Phenotypic evaluation of strains
The 11 MAR mutants, 7 Salmonella Typhimurium and 4 E. coli, selected after antibiotic or biocide exposure were all cyclohexane tolerant and had reduced susceptibility to the antibiotics tested (Table 1) . Small increases in the MIC of ciprofloxacin were also observed in the mutants with disruption of the outer membrane proteins. Increased susceptibility to antibiotics was detected in the acrB::aph, tolC::aph and DacrBacrF::aph gene disruption mutants. H33342 had no statistically significant effect on the viability of SL1344 at the concentration of 2.5 mM used in the assay.
Accumulation of H33342 by parental and multiply antibiotic-resistant strains
In preliminary studies, the effect of H33342 concentration (100, 10 and 2.5 mM) on fluorescence in the parental and MAR Salmonella Typhimurium strains was evaluated over a 30 min incubation period. Optimal discrimination between the accumulation for the parental and MAR strains was achieved with a H33342 concentration of 2.5 mM (data not shown); this concentration of H33342 (2.5 mM) was selected for all subsequent investigations. The utility of H33342 accumulation as an assay for MAR in Salmonella Typhimurium and E. coli was evaluated by comparison of 11 MAR mutants with the appropriate parental strain and heat-inactivated parent cells that served as a positive control (Table 2) . Heat-inactivated cells rapidly accumulated maximal levels of H33342. Accumulation of H33342 by the tetracycline-selected MAR Salmonella Typhimurium (ST-MAR1 -4) mutants was significantly (P,0.0001) reduced (mean+SD) by an average of 47.2+8.3% and 42.5+7.3% at 15 and 30 min, respectively, compared with the parental strain, SL1344. The accumulation of H33342 by heat-inactivated cells, the parental strain SL1344 and the 4 tetracycline-selected Salmonella Typhimurium MAR mutants (ST-MAR1 -4) over a 30 min incubation period is provided in Figure 2 . The Salmonella Typhimurium MAR strains selected after repeated exposure to biocides (OXCR1, QACFGR2, TOPR2) also accumulated H33342 at a reduced (P,0.0001) rate compared with SL1344 (Table 2) . Significantly (P,0.0001) reduced accumulation of H33342 at 15 and 30 min was observed in 3 (EC-MAR1, 2 and 3) of the 4 MAR E. coli strains (EC-MAR1 -4) by an average of 18.7+12.3% and 13.2+10.2% at 15 and 30 min, respectively ( Table 2 ).
Accumulation of H33342 by parental and gene-inactivated strains
The contribution of specific efflux pumps and porins (that have been associated with MAR) to H33342 accumulation was evaluated using the Salmonella Typhimurium gene disruption mutants. Loss of components of AcrAB-TolC and AcrF resulted in significantly (P,0.0001) increased accumulation of H33342 within the cell (Table 2 ). In contrast, loss of porins was associated Fluorescence assay for MAR 1657 JAC with lower accumulation of H33342, although this was not to the same extent as that observed in the MAR mutants.
Sensitivity to efflux pump inhibitors
The effect of the efflux pump inhibitors, CCCP (0.1-10 mM) and PAbN (0.33 -333 mM), was evaluated by monitoring H33342 accumulation in SL1344. Both inhibitors provided dosedependent increases in H33342 accumulation over the concentration ranges tested (Figure 3) . Sensitivity of Salmonella Typhimurium SL1344 and the ST-MAR1 mutant to the effects of the efflux pump inhibitors CCCP (10 mM) and PAbN (333 mM) on H33342 accumulation was compared over 30 min (Figure 4) . The MAR mutant ST-MAR1 demonstrated reduced (P,0.0001) susceptibility to both inhibitors compared with the parental strain, SL1344 (Figure 4 ). The accumulation of H33342 and the effect of CCCP (10 mM) and PAbN (333 mM) was also investigated in the biocide-selected mutants, TOPR2, OXCR1 and QACFGR2. The fluorescence of the TOPR2 mutant was 15% lower than that of the parent and showed significantly (P,0.0001) greater resistance to PAbN compared with the parental strain (Figure 5a ). The accumulation of H33342 by the OXCR1 mutant was 40% lower than that of the parent and showed significantly (P,0.0001) greater resistance to both CCCP and PAbN than the parental strain. The QACFGR2 mutant gave similar data to the OXCR1 mutant (data not shown). All of the biocide-derived MAR mutants showed similar sensitivity to PAbN, but the OXCR1 and QACFCR2 strains were much more resistant to CCCP (Figure 5b ). The accumulation of H33342 was also significantly (P,0.0001) increased in all E. coli MAR mutants exposed to CCCP and PAbN (data not shown). The mutants with disruption of ompF and ompC genes were also sensitive to CCCP (10 mM) and PAbN (333 mM), but accumulation of H33342 in the presence of these inhibitors did not reach the same level as that observed in the parent strain SL1344 (data not shown).
Comparison of accumulation of H33342, norfloxacin and ethidium bromide
The intracellular accumulations of H33342, norfloxacin and ethidium bromide were compared between SL1344 and isogenic derivatives lacking either tolC or acrB. The results (Figure 6a) indicated that all tests provided very similar levels of accumulation by each of the mutant strains when compared with their parent, SL1344. The accumulation of H33342 and ethidium bromide by SL1344 in the presence and absence of the efflux pump inhibitors PAbN and CCCP was also compared (Figure 6b ). Although both inhibitors produced significantly (P,0.05) increased accumulation of either H33342 or ethidium bromide, this was proportionately much greater with H33342 in the presence of PAbN.
Discussion
The MAR phenotype is characterized by reduced susceptibility to unrelated antibiotics and biocides. This can be mediated by a Coldham et al.
single mechanism such as increased efflux and is usually identified by multiple assessment of the MICs of a range of agents. This is a time-consuming and relatively expensive methodology in terms of labour. Although the cyclohexane tolerance test has been suggested as a simple marker for MAR, it has poor specificity 12 and there is currently no accepted single test. In the present study, a new technique based on the rapid determination of intracellular accumulation of the fluorescent dye H33342 was evaluated as a test for MAR. MAR mutants, produced by a variety of means and with diverse phenotypes, with a single exception (EC-MAR4), all showed reduced accumulation of H33342 when compared with their parental strain. We have previously phenotypically characterized the Salmonella Typhimurium mutants, and the proteomes of ST-MAR1 and the disinfectant-selected mutants have been assessed. 25, 28 The ST-MAR1, OXCR1 and QACFGR2 strains all had significantly increased expression of the AcrAB-TolC efflux pump relative to their common parent, SL1344. 25, 29 In contrast, there was no change in the expression of the AcrAB-TolC efflux pump in the TOPR2 mutant, but there was reduced expression of certain outer membrane porins including OmpF. The TOPR2 mutant also had the smallest difference in H33342 accumulation relative to SL1344, suggesting that H33342 is a substrate of AcrAB-TolC.
The disruption of certain efflux pump genes that conferred multi-antibiotic susceptibility significantly increased H33342 accumulation. The outer membrane protein TolC forms a channel through the outer membrane for the extrusion of substrates of inner membrane pumps including AcrAB and EmrAB. 7 Disruption of tolC significantly increased H33342 accumulation; a similar effect was observed with an acrB disruptant ( Table 2 ). Accumulation of H33342 was further increased following disruption of both acrB and acrF in a double mutant strain. Increased accumulation of ethidium bromide has been observed in E. coli following disruption of acrAB. Fluorescence assay for MAR 1659 JAC studies have revealed increased translation and transcription of acrD and acrF upon disruption of acrB, suggesting their coordinated regulation. 30 A role for acrF in the active efflux of H33342 was further supported by the greatly increased rate of accumulation of H33342 by the acrB-acrF::aph mutant compared with the single acrB::aph disruptant. As found previously, the MICs of the antibiotics tested were also much lower following disruption of acrB and acrF than acrB alone.
The ability of this test to identify mutants with repressed porin production was also evaluated; strains with disruption to the genes encoding the outer membrane proteins OmpC, OmpF, OmpW and OmpX also had reduced accumulation of H33342. Reduced expression of OmpF also contributes to MAR by reducing entry of substrates into the bacterial cytoplasm. 31 The functions of OmpX and OmpW are not well known; the former has been associated with virulence and cation selectivity 32 and the latter with transport of small hydrophilic molecules 33 and colicin S4 accumulation. 34 Thus, reduced accumulation of H33342 in these mutants with disruptions to outer membrane proteins was consistent with their porin function and selectivity. This also demonstrated the sensitivity of H33342 accumulation to detection of disruption of porin proteins, which is not commonly possible by assessment of MIC changes since these were within one doubling dilution of that for the parental strain and within experimental error of the MIC determination method.
Two inhibitors of active efflux, PAbN and CCCP, were utilized to determine the contribution of active efflux to transport of H33342 by these strains. PAbN has been described as a broadspectrum efflux pump inhibitor in a wide range of Gram-negative bacteria, and a binding site for this molecule has been proposed within AcrB. 9 CCCP is a protonophore and inhibits processes 5) in the presence and absence of efflux pump inhibitors was sufficient to identify strains where MAR was a result of increased active efflux. Comparison between the parent and ST-MAR1 mutant revealed components in the latter for reduced H33342 accumulation that were resistant to both efflux pump inhibitors. Such resistance to inhibitors was also detected in the OmpC and OmpF gene disruption mutants and thus consistent with reduced expression of these porins in the ST-MAR1 mutant. Further comparative sensitivity of the OXCR1, TOPR2 and QACFGR2 MAR mutants, where the expression of efflux pump proteins and outer membrane proteins has been determined, 25 provided a further insight into the likely molecular mechanism of MAR. While CCCP and PAbN increased H33342 accumulation in the OXCR1 and QACFGR2 MAR mutants, it was not to the same level as that observed with the TOPR2 mutant, which, upon addition of CCCP, accumulated as much H33342 as the parent strain. This sensitivity to CCCP indicated that the TOPR2 mutant had a significant efflux mechanism of MAR, but different from AcrAB-TolC. Reduced sensitivity of the OXCR1 and QACFGR2 MAR mutants to both inhibitors was consistent with an additional component, such as reduced porin protein expression, and this was confirmed by proteomic analysis, 25 but may also reflect active efflux of CCCP and PAbN.
Other workers have utilized a similar principal to that exploited here and used ethidium bromide as an intercalating fluorescent dye to monitor cellular permeability and active efflux. 17, 35, 36 However, we believe that the use of H33342 has several significant advantages over ethidium bromide as a marker of intracellular accumulation. Principal amongst these benefits is the reduced effect of quenching on signal produced by H33342 and the higher quantum yield of this probe that provides for much greater sensitivity. There are also fewer toxicological concerns associated with the use of H33342 when compared with ethidium bromide. A comparison between assays for the accumulation of H33342 and ethidium bromide Fluorescence assay for MAR 1661 JAC produced similar data, but sensitivity, particularly to PAbN, was much greater with H33342. In summary, we describe a highly sensitive and specific test that is cheap, relatively quick and can be performed in a 96-well plate for the determination of cellular permeability of Gram-negative bacteria. The H33342 based assay is flexible and it may be used in combination with specific efflux inhibitors to rapidly identify strains that are likely to be MAR and the contribution of efflux pumps and porins to that phenotype. This approach may have further value as a screening tool of compound libraries for new efflux pump inhibitor molecules. 
